MNKD MannKind Corp
Company Analysis
Latest News
🟢 MannKind is trading 7% up
MannKind is trading at $3.97, up 6.97%, with no company-specific announcement identified as a catalyst. - No new MannKind-specific announcement was identified...
🟢 MannKind is trading 8% up in pre-market with no identified company catalyst
MannKind is trading at $4.02, up 7.77%, with no new company announcement identified to explain the November 4 pre-market move. - MannKind’s investor relations...
MannKind Corp Q3 2026 Earnings Preview: What Analysts Expect on November 05, 2026
Analysts expect MannKind Corp to report Q3 2026 revenue of approximately $107.74 million and an EPS of -$0.08, with the current stock price of $3.50 trading...
MannKind Corp Q3 2026 Earnings Preview: What Analysts Expect on November 04, 2026
MannKind is expected to report third-quarter 2026 revenue of $107.74 million (+31.2% YoY) and a consensus EPS of -$0.06, while the stock currently trades near...
🔴 MannKind is trading 12.53% down in pre-market — catalyst remains unclear
MannKind is trading at $3.00 (-12.53%) in pre-market, with no specific catalyst identified for the October 29 move. - MannKind’s newsroom latest listed...
🔴 MannKind is trading 5% down in pre-market
MannKind is trading 5.47% down in pre-market at $3.11 on October 28; no confirmed catalyst for the move was identified. - The price compares with the October...
🔴 MannKind is trading 5% down amid weakness across biotech stocks
MannKind is trading 5.02% down at $3.03, in line with pressure on smaller biotech stocks as risk appetite weakens. - No clear company-specific announcement...
🔴 MannKind is trading 5% down with no clear catalyst identified
MannKind is trading at $3.12, down 5.16%, with no clear catalyst identified for the October 12 decline. - Latest company news was supportive Furoscix ReadyFlow...
🔴 MannKind is trading 5% down today — no clear catalyst
MannKind is trading 5.19% lower at $3.24 on October 9, 2026, with no clearly reported event today explaining the decline. - The latest company-specific item...
🔴 MannKind is trading 5% down today as biotech and broader risk-off pressures weigh
MannKind is trading 5.39% lower at $3.51 on October 7, with biotech and broader risk-off pressure weighing on shares. - MannKind closed down 2.88% on October...
🟢 MannKind is trading 7.6% up in pre-market with no clear catalyst identified
MannKind is trading at $4.09, up 7.60%, with no clear company-specific catalyst identified for the move. - No clear company-specific announcement or fresh...
🔴 MannKind is trading 5.6% down today
MannKind is trading 5.6% down at $3.73, with no clear company-specific announcement or same-day catalyst identified in the available news search. - Recent...
🟢 MannKind is trading 6.5% up today with no clear catalyst identified
MannKind is trading at $4.16, up 6.54% on October 1, 2026, with no new company announcement identified. - September 30 coverage called the Delaware ruling...
🟢 MannKind is trading 16.3% up today with broader market gains a possible factor
MannKind is trading at $3.88, up 16.32%, with broader market strength a possible backdrop, though no direct cause is established. - No company-specific...
🟢 MannKind is trading 6.9% up today with broader markets higher
MannKind is trading at $3.57, up 6.87%, with the move appearing more consistent with broad market strength than a confirmed company catalyst. - The S&P 500...
🔴 MannKind is trading 5.6% down today with no clear company-specific catalyst
MannKind is trading 5.6% down at $3.31, with no clearly identified company-specific catalyst for the September 22, 2026 decline. - Recent coverage focused on...
🔴 MannKind is trading 5% down today after broader biotech weakness
MannKind is trading 5.1% down at $3.56 as broader biotech weakness pressures commercial-stage drugmakers. - The biotech sector is down 2.11% as investors...
🔴 MannKind is trading 5.17% down today amid broader market pressure
MannKind is trading 5.17% down now at $3.94 as broader markets remain under pressure. - The S&P 500 is down 0.49%, the NASDAQ Composite is down 0.62%, and the...
🟢 MannKind is trading 5.6% up; reason remains unconfirmed
MannKind is trading 5.6% up now at $4.29, with the reason unconfirmed. - No clear September 8, 2026 company-specific catalyst was identified; the latest...
Wellington Management doubles MannKind stake with 4.5 million share buy
Wellington Management Group LLP increased its investment in MannKind Corporation by purchasing 4,561,628 additional shares. A recent SEC Form 13F filing...